TY - JOUR T1 - Assessment of faecal microbial transfer in irritable bowel syndrome with severe bloating JF - Gut JO - Gut SP - 980 LP - 982 DO - 10.1136/gutjnl-2016-312513 VL - 66 IS - 5 AU - Tom Holvoet AU - Marie Joossens AU - Jun Wang AU - Jerina Boelens AU - Bruno Verhasselt AU - Debby Laukens AU - Hans van Vlierberghe AU - Pieter Hindryckx AU - Martine De Vos AU - Danny De Looze AU - Jeroen Raes Y1 - 2017/05/01 UR - http://gut.bmj.com/content/66/5/980.abstract N2 - We read with interest the work by Halmos et al1 in which they describe the effects of dietary FODMAP (Fermentable Oligo-, Di- and Mono- saccharides And Polyols) restriction in patients with IBS on the intestinal microbiota. They showed that low FODMAP intake was associated with reduced total bacterial and lower relative abundance of butyrate-producing Clostridium cluster XIVa, changes that are generally considered unfavourable.2 Therefore, they discourage long-term dietary FODMAP restriction, a suggestion also supported by the recent work of McIntosh and colleagues who noticed unfavourable changes in both microbiota and metabolome of patients with IBS who were on a low FODMAP diet.3 Although low FODMAP intake reduces GI symptoms in almost 75% of patients with IBS, the effects of this diet on the intestinal microbiota might be disadvantageous in the long run.Combining these observations with the important role for the intestinal microbiota in IBS pathogenesis,4 we report here faecal microbiota transplantation (FMT) as an alternative to FODMAP restriction in patients with IBS. We applied FMT in 12 refractory IBS patients (Rome III criteria) with intermittent diarrhoea and severe bloating, … ER -